MDT

87.75

+0.22%↑

A

114.9

+0.58%↑

VEEV

148.45

-7.44%↓

HQY

81.99

-1.44%↓

TLRY

6.73

+1.2%↑

MDT

87.75

+0.22%↑

A

114.9

+0.58%↑

VEEV

148.45

-7.44%↓

HQY

81.99

-1.44%↓

TLRY

6.73

+1.2%↑

MDT

87.75

+0.22%↑

A

114.9

+0.58%↑

VEEV

148.45

-7.44%↓

HQY

81.99

-1.44%↓

TLRY

6.73

+1.2%↑

MDT

87.75

+0.22%↑

A

114.9

+0.58%↑

VEEV

148.45

-7.44%↓

HQY

81.99

-1.44%↓

TLRY

6.73

+1.2%↑

MDT

87.75

+0.22%↑

A

114.9

+0.58%↑

VEEV

148.45

-7.44%↓

HQY

81.99

-1.44%↓

TLRY

6.73

+1.2%↑

Search

Cencora Inc

Abrir

SetorSaúde

316.04 -2.34

Visão Geral

Variação de preço das ações

24h

Atual

Mín

313.04

Máximo

324.83

Indicadores-chave

By Trading Economics

Rendimento

906M

566M

Vendas

2.2B

86B

P/E

Médio do Setor

38.623

66.418

EPS

4.08

Rendimento de Dividendos

0.69

Margem de lucro

0.659

Funcionários

47,000

EBITDA

858M

1B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+25.53% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.69%

2.36%

Próximos Ganhos

6 de mai. de 2026

Próxima data de dividendos

1 de jun. de 2026

Próxima data de ex-dividendo

15 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-8.3B

62B

Abertura anterior

318.38

Fecho anterior

316.04

Sentimento de Notícias

By Acuity

6%

94%

8 / 348 Ranking em Healthcare

Cencora Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB: Higher Energy Prices to Raise Production, Consumer Costs

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects Japan GDP Growth at 0.7% in 2026, 0.6% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects South Korea GDP Growth at 1.9% in 2026, 1.9% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

Extent of Slowdown Hinges on Duration of MidEast Conflict, ADB Says

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects India GDP Growth at 6.9% in 2026, 7.3% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects China GDP Growth at 4.6% in 2026, 4.5% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Pojects Australia GDP Grrowth at 2.0% in 2026, 2.9% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects Taiwan GDP Growth at 7.6% in 2026, 4.0% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

Geopolitical Risks Make Asia's Economic Outlook Highly Uncertain, ADB Says

10 de abr. de 2026, 00:00 UTC

Notícias Principais

Asia Regional Growth Likely to Moderate in 2026-2027, ADB Says

9 de abr. de 2026, 23:44 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

9 de abr. de 2026, 23:34 UTC

Conversa de Mercado

Gold Edges Lower Amid Lingering Inflation Concerns -- Market Talk

9 de abr. de 2026, 23:14 UTC

Conversa de Mercado

Jefferies Upbeat on Australian Miners, But Recession a Key Risk -- Market Talk

9 de abr. de 2026, 23:14 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

9 de abr. de 2026, 23:07 UTC

Conversa de Mercado

Centaurus's Supply Deal with Glencore Supports Jaguar Development -- Market Talk

9 de abr. de 2026, 22:54 UTC

Conversa de Mercado

Transurban Lacks Appeal as Higher Fuel Prices Slow Traffic -- Market Talk

9 de abr. de 2026, 22:31 UTC

Notícias Principais

Trump on Truth Social: 'That Is Not the Agreement We Have!'

9 de abr. de 2026, 22:31 UTC

Notícias Principais

Trump on Truth Social: 'Iran Is Doing a Very Poor Job, Dishonorable Some Would Say, of Allowing Oil to Go Through the Strait of Hormuz'

9 de abr. de 2026, 20:57 UTC

Notícias Principais

U.S. Oil Prices Are Back Near $100 After Israel Keeps Up Air Strikes on Lebanon -- Barrons.com

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

9 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

9 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de abr. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone Investment Positions Rowan to Continue Delivering Sustainable Data Center Capacity for World's Leading Technology Cos >BX

9 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone Blackstone Acquired Significant Minority Stake in Rowan Digital Infrastructure >BX

9 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Rowan Digital Infrastructure Announces Strategic Recapitalization

9 de abr. de 2026, 20:25 UTC

Aquisições, Fusões, Aquisições de Empresas

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

9 de abr. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

9 de abr. de 2026, 19:30 UTC

Notícias Principais

How Digital Currencies Have Helped Iran -- WSJ

Comparação entre Pares

Variação de preço

Cencora Inc Previsão

Preço-alvo

By TipRanks

25.53% parte superior

Previsão para 12 meses

Média 404.78 USD  25.53%

Máximo 440 USD

Mínimo 360 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Cencora Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

10 ratings

9

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

8 / 348 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat